These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16978735)

  • 21. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ; Rojtman A; Tran K
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
    Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
    J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak.
    Holländer R; Ebke M; Barck H; von Pritzbuer E
    J Hosp Infect; 2001 Jul; 48(3):207-13. PubMed ID: 11439008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan.
    Fukigai S; Alba J; Kimura S; Iida T; Nishikura N; Ishii Y; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):306-10. PubMed ID: 17276038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
    Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
    Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases.
    Randrianirina F; Vedy S; Rakotovao D; Ramarokoto CE; Ratsitohaina H; Carod JF; Ratsima E; Morillon M; Talarmin A
    J Hosp Infect; 2009 May; 72(1):23-9. PubMed ID: 19282056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Inoue M
    J Infect Chemother; 2001 Jun; 7(2):124. PubMed ID: 11455505
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
    Huttner B; Pittet D; Harbarth S
    J Antimicrob Chemother; 2008 Nov; 62(5):1165; author reply 1165-6. PubMed ID: 18658195
    [No Abstract]   [Full Text] [Related]  

  • 30. Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in liver transplant recipients.
    Lübbert C; Rodloff AC; Laudi S; Simon P; Busch T; Mössner J; Bartels M; Kaisers UX
    Liver Transpl; 2014 Jun; 20(6):736-8. PubMed ID: 24677425
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli acquisition in a tertiary care teaching hospital in Thailand.
    Chaiwarith R; Pasogpakdee P; Salee P; Kanjanaratanakorn K; Sirisanthana T; Supparatpinyo K
    J Hosp Infect; 2009 Mar; 71(3):285-6. PubMed ID: 19157645
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of an ACC-1-producing Klebsiella pneumoniae outbreak in a physical medicine and rehabilitation unit.
    Ohana S; Denys P; Guillemot D; Lortat-Jacob S; Ronco E; Rottman M; Bussel B; Gaillard JL; Lawrence C
    J Hosp Infect; 2006 May; 63(1):34-8. PubMed ID: 16519958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).
    Maltezou HC; Giakkoupi P; Maragos A; Bolikas M; Raftopoulos V; Papahatzaki H; Vrouhos G; Liakou V; Vatopoulos AC
    J Infect; 2009 Mar; 58(3):213-9. PubMed ID: 19246099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An outbreak of extended-spectrum beta-lactamase-producing Klebsiella species in a neonatal intensive care unit in Brazil.
    Otman J; Cavassin ED; Perugini ME; Vidotto MC
    Infect Control Hosp Epidemiol; 2002 Jan; 23(1):8-9. PubMed ID: 11868896
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.
    Ktari S; Arlet G; Mnif B; Gautier V; Mahjoubi F; Ben Jmeaa M; Bouaziz M; Hammami A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4198-201. PubMed ID: 17015633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases.
    García San Miguel L; Cobo J; Valverde A; Coque TM; Diz S; Grill F; Cantón R
    Clin Microbiol Infect; 2007 May; 13(5):532-8. PubMed ID: 17263834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Extended-spectrum beta-lactamase production and antimicrobial resistance patterns of Klebsiella pneumoniae strains isolated from nosocomial bacteremic patients: evaluation of the results of 2001-2005 period].
    Taşbakan MI; Pullukçu H; Sipahi OR; Aydemir S; Arda B; Yamazhan T; Tunger A; Ulusoy S
    Mikrobiyol Bul; 2008 Jan; 42(1):1-7. PubMed ID: 18444557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment.
    Alrabaa SF; Nguyen P; Sanderson R; Baluch A; Sandin RL; Kelker D; Karlapalem C; Thompson P; Sams K; Martin S; Montero J; Greene JN
    Am J Infect Control; 2013 Jun; 41(6):562-4. PubMed ID: 23171594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.